All News

Stephanie Pearson, MD, provides some tips for ergonomics within obstetrics and gynecology.

A new study finds that infections such as chlamydia, gonorrhea, and syphilis during pregnancy significantly increase the risk of stillbirth, preterm birth, and low birth weight.

The World Health Organization’s evidence-based recommendations aim to improve care and outcomes for pregnant women with sickle cell disease.

"The FDA did not raise any concern regarding the general approvability of elinzanetant in its correspondence," according to an anouncement from Bayer.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

A new study finds that intrahepatic cholestasis of pregnancy diagnosis before 32-weeks’ gestation increases the risk of adverse outcomes.

Kephera Diagnostics announced the launch of EndomTest, a noninvasive blood test for endometriosis, promising faster diagnoses and improved patient care.

A study finds that a uniform labor induction protocol did not reduce racial disparities in cesarean deliveries or maternal health outcomes.

The FDA has granted priority review to expand flibanserin (Addyi; Sprout Pharmaceuticals) use to postmenopausal women, potentially broadening access to treatment for hypoactive sexual desire disorder.

A new study finds that restrictive abortion legislation significantly increases maternal health risks in pregnancies with life-limiting fetal diagnoses.

Study finds USPSTF guidelines label 89% of pregnancies as at risk for preeclampsia, but moderate risk factors offer limited value in guiding aspirin use.

Learn the truth about estrogen therapy, including its safety, benefits, and the critical differences between local and systemic hormone treatments.

Women with hypertensive disorders of pregnancy are more likely to never start or stop breastfeeding early, according to a recent study.

A new study highlights the urgent need for standardized, globally applicable guidelines to improve the diagnosis and management of placenta accreta spectrum.

Experts debate the risks and benefits of SSRIs during pregnancy, emphasizing the need for better education and transparency in treatment options.

A new review reveals that maternal depression significantly impairs bonding, sensitivity, and emotional engagement among mothers.

New research suggests oxytocin could help reduce mood disturbances caused by sleep disruption during menopause and postpartum.

Experts urge the FDA to update outdated warnings on menopausal hormone therapies, emphasizing the safety and benefits of low-dose vaginal estrogen.

Nearly one-third of women with premature ovarian insufficiency experience depressive symptoms, according to a recent study.

Infants born preterm or with complications face higher risks of chronic conditions in adulthood, highlighting policy and health care needs.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

New research reveals that existing USPSTF guidelines may overgeneralize preeclampsia risk, highlighting the need for biologically based, personalized screening methods to improve maternal outcomes.

DiaMedica Therapeutics' investigational therapy DM199 significantly reduced blood pressure and improved uterine blood flow in patients with preeclampsia, with a favorable safety profile.

Tirzepatide and menopause hormone therapy may significantly enhance weight loss and health outcomes in postmenopausal women.

Research reveals significant treatment gaps for hepatitis C in postpartum women and children, highlighting urgent needs for improved care access and awareness.

A national study reveals that fewer than 1 in 3 children with hepatitis C receive care, with significant gaps linked to race, region, and age.

A 28-day low FODMAP diet significantly reduces gastrointestinal symptoms and improves quality of life in women with endometriosis.

A new study finds first-trimester trimethoprim-sulfamethoxazole use increases the risk of congenital malformations compared with β-lactam antibiotics.